Clinical Trial Update: Immunogenicity of Gardasil-9 HPV Vaccine in People Living With HIV [Phase 4]

View source ↗

Summary

Phase 4 trial evaluating immunogenicity of Gardasil-9 HPV vaccine in people living with HIV is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Anal Intraepithelial Neoplasia
• Cervical Intraepithelial Neoplasia
• Human Papillomavirus Infection
• Oral Hpv Infection

Drugs mentioned

• Gardasil 9 (Human papillomavirus vaccine, 9-valent)

Snippet

Sponsor: Louisiana State University Health Sciences Center in New Orleans | Conditions: Papillomavirus Vaccines, Human Immunodeficiency Virus | Phase 4 | Status: RECRUITING